Clinical Research Directory
Browse clinical research sites, groups, and studies.
Improving Medication Management in World Trade Center Responders
Sponsor: Icahn School of Medicine at Mount Sinai
Summary
By 2030, the majority of World Trade Center (WTC) rescue and recovery workers (responders) will be aged 65 and over and at risk for aging-related conditions and consequences including the concurrent use of five or more medications (i.e., polypharmacy). The purpose of this research study is to investigate an educational approach targeting polypharmacy through de-prescribing unnecessary and burdensome medications via the support of informed discussions between WTC responders and their prescribing physicians.
Official title: Promoting Healthy Aging Among WTC Responders: Frailty Trajectories And Intervention Strategies
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-04-08
Completion Date
2026-06-30
Last Updated
2025-06-15
Healthy Volunteers
No
Conditions
Interventions
Educational brochure for deprescribing
Study participant will be provided information (i.e., educational brochure) about one of the five medication classes participants may be taking that are known to have potential side effects for older adults: proton pump inhibitors (PPIs), benzodiazepine (BZs) and non-benzodiazepine sedative hypnotics ("Z-drugs"), first-generation antihistamines (FGA), and skeletal muscle relaxants (SMR) to determine their necessity.
Locations (1)
Icahn School of Medicine at Mount Sinai
New York, New York, United States